search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
GREATER INSIGHTS. BETTER OUTCOMES.


Stop by Booth 518 at the DATIA Conference to visit with CRL’s scientific leaders and discover why we remain the leader in innovation, laboratory automation and turnaround time to support your business. Plus, ask for your free 2019 CRL Industry Insight Report, which includes updates on synthetic cannabinoids and other new assays offered by CRL.


MEET OUR SCIENTIFIC THOUGHT LEADERS


David J. Kuntz, PhD, F-ABFT Executive Director of Analytical Toxicology


Dr. Kuntz is a Board Certified Toxicologist and is a national expert in urine adulteration and drug detection in urine, oral fluid, hair, and sweat using GC/ MS and LC/MS/MS. Dr. Kuntz has worked in workplace drug testing for the past 30 years and has testified extensively regarding drug use, interpretation, and adulteration of urine, oral fluid and sweat samples. The primary research focus the last five years has been in the development of testing panels for synthetic cannabinoids and bath salts in urine and oral fluids.


Dr. Kuntz is an inspector for the SAMHSA and CAP forensic drug testing programs and a past member of the national Drug Testing Advisory Board, NLCP MSMS Standards Working Group, editorial board for Clinical & Forensic Toxicology News. Dr. Kuntz is currently serving as a consultant to the MRO Examination Development Committee for the Medical Review Officer Certification Council (MROCC) and lecturer for AAMRO training courses.


Heather Fehling PH.D., HCLD Vice President Of Laboratory Sciences / Deputy Chief Scientific Officer


Dr. Fehling has been with CRL since 2008 and is a certified High Complexity Laboratory Director (HCLD) by the American Board of Bioanalysis (ABB). Dr. Fehling leads CRL’s Personalized Medicine efforts and serves as the HCLD for CRL’s Molecular Diagnostics / Esoteric Laboratory. More broadly, Dr. Fehling provides scientific leadership across all laboratories at CRL with her extensive experience in laboratory management, new assay development, quality control, and business development. Dr. Fehling currently serves as a board member for ABB as well as the American Association of Bioanalysts (AAB).


Greater Insights. Better Outcomes.®


Visit crlcorp.com or call 800.445.6917 8433 Quivira Road, Lenexa, Kansas 66215


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56